Eli Lilly Jumps, EchoStar Soars, UnitedHealth Drops

On this episode of Stock Movers:

- Eli Lilly (LLY) shares jumped after the company shared their obesity pill helped patients lose 9.6% of their body weight in a trial. It's the second trial; the first was conducted earlier this month and disappointed investors who had been expecting higher weight loss and lower rates of side effects.

- EchoStar (SATS) has agreed to sell spectrum licenses to AT&T Inc. for about $23 billion in a deal that will help the company stay out of bankruptcy and fend off regulatory concerns about its airwave use. The sale will expand AT&T’s network and add about 50 MHz of low-band and mid-band spectrum in an all-cash transaction, the Dallas-based telecommunications company said in a statement on Tuesday. The deal is expected to close by mid-2026, pending regulatory approval. Both the White House and the Federal Communications Commission were briefed about the transaction before the announcement, according to multiple people familiar with the discussions who asked to not be identified because the talks were private. America’s leadership in wireless services has a been a priority for President Donald Trump, according to a White House official, who said the president believes this deal will accelerate the use of the wireless spectrum.

- The US Justice Department’s criminal division is digging into UnitedHealth Group’s (UNH) prescription management services as well as how it reimburses its own doctors under an ongoing probe into the firm’s operations, according to people familiar with the matter. UnitedHealth shares dropped 1.5% at the New York market close, reversing earlier gains.

See omnystudio.com/listener for privacy information.